Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up

Hobday, K; Hulme, J; Belton, S; Homer, CSE; Prata, N

Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up

Hobday, K Hulme, J Belton, S Homer, CSE

Prata, N

Permalink

Publication Type:: Journal Article
Citation:: Global Public Health, 2018, 13 (8), pp. 1081 - 1097
Issue Date:: 2018-08-03

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Accepted Manuscript VersionAdobe PDF (372.73 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Hobday, K	en_US
dc.contributor.author	Hulme, J	en_US
dc.contributor.author	Belton, S	en_US
dc.contributor.author	Homer, CSE https://orcid.org/0000-0002-7454-3011	en_US
dc.contributor.author	Prata, N	en_US
dc.date.available	2020-05-25T19:13:14Z
dc.date.issued	2018-08-03	en_US
dc.identifier.citation	Global Public Health, 2018, 13 (8), pp. 1081 - 1097	en_US
dc.identifier.issn	1744-1692	en_US
dc.identifier.uri	http://hdl.handle.net/10453/90092
dc.description.abstract	© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.	en_US
dc.relation.ispartof	Global Public Health	en_US
dc.relation.isbasedon	10.1080/17441692.2017.1303743	en_US
dc.subject.classification	Public Health	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Postpartum Hemorrhage	en_US
dc.subject.mesh	Misoprostol	en_US
dc.subject.mesh	Anti-Ulcer Agents	en_US
dc.subject.mesh	Evidence-Based Medicine	en_US
dc.subject.mesh	Pregnancy	en_US
dc.subject.mesh	Community Health Services	en_US
dc.subject.mesh	Female	en_US
dc.title	Community-based misoprostol for the prevention of post-partum haemorrhage: A narrative review of the evidence base, challenges and scale-up	en_US
dc.type	Journal Article
utslib.citation.volume	8	en_US
utslib.citation.volume	13	en_US
utslib.for	1117 Public Health and Health Services	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
pubs.organisational-group	/University of Technology Sydney/Strength - WHO CC
utslib.copyright.status	open_access
pubs.issue	8	en_US
pubs.publication-status	Published	en_US
pubs.volume	13	en_US

Abstract:

© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Achieving Sustainable Development Goal targets for 2030 will require persistent investment and creativity in improving access to quality health services, including skilled attendance at birth and access to emergency obstetric care. Community-based misoprostol has been extensively studied and recently endorsed by the WHO for the prevention of post-partum haemorrhage. There remains little consolidated information about experience with implementation and scale-up to date. This narrative review of the literature aimed to identify the political processes leading to WHO endorsement of misoprostol for the prevention of post-partum haemorrhage and describe ongoing challenges to the uptake and scale-up at both policy and community levels. We review the peer-reviewed and grey literature on expansion and scale-up and present the issues central to moving forward.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/90092